8QQ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abcellera Biologics Inc

Watchlist Manager

Watchlist

Price: 5.65 EUR -4.07% Market Closed

Market Cap: €1.7B

A	Abcellera Biologics Inc F:8QQ	CA
	Grail Inc F:NL0	US
M	Mazda Motor Corp F:MZA	JP

Profitability Summary

Abcellera Biologics Inc's profitability score is 9/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-289%

Negative 3Y Average Operating Margin

-715%

Declining Operating Margin

-80% > -289%

Negative Net Margin

-195%

Negative 3Y Average Net Margin

-416%

Declining Net Margin

-51% > -195%

Negative Free Cash Flow Margin

-232%

Negative 3Y Average Free Cash Flow Margin

-401%

Declining Free Cash Flow Margin

-130% > -232%

Negative ROE

-14%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-30%

Declining ROIC

-19% > -24%

View All

Hide

Collapse

9 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.